Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1 study found for:    11406550 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Terminated Lymphocyte Reconstitution After Administration of Pegfilgrastim Versus Filgrastim After Peripheral Stem Cell Transplantation
Condition: Non Hodgkin Lymphoma
Interventions: Drug: Pegfilgrastim;   Drug: Filgrastim

Study has passed its completion date and status has not been verified in more than two years.